Brain GABA Levels and Treatment Response in Major Depressive Disorder
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
This study will evaluate changes in brain gamma-aminobutyric acid (GABA) levels due to
treatment with escitalopram in people with major depressive disorder.